PhenoVista Biosciences

Founded with a mission to revolutionize drug discovery, PhenoVista Biosciences is a niche contract research organization (CRO) specializing in high-content imaging-based phenotypic assay development and screening services. The company leverages state-of-the-art technology to offer phenotypic screen feasibility, development, and full-scale campaigns, working closely with clients to deliver precise data efficiently and cost-effectively. PhenoVista Biosciences primarily serves top pharmaceutical companies, focusing on de-risking R&D decisions and increasing the likelihood of successful drug candidates.

PhenoVista Biosciences boasts a team of expert cell biologists and has completed over 500 custom studies, imaging more than 1.2 million wells and staining over 4 billion cells. The company’s notable achievements include a 90% client base from top pharmaceutical firms and an 80% repeat customer rate, underscoring its reliability and impact in the industry. By providing quantitative data and biological insights through high-content imaging, PhenoVista Biosciences significantly enhances the drug discovery process, contributing to the development of first-in-class therapeutics.